iSpecimen Inc (ISPC)
0.265
0.00 (0.00%)
USD |
NASDAQ |
May 02, 14:24
iSpecimen Enterprise Value: -2.552M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | -2.552M |
| April 30, 2024 | -2.361M |
| April 29, 2024 | -2.288M |
| April 26, 2024 | -2.588M |
| April 25, 2024 | -2.459M |
| April 24, 2024 | -2.481M |
| April 23, 2024 | -2.324M |
| April 22, 2024 | -1.916M |
| April 19, 2024 | -2.386M |
| April 18, 2024 | -1.180M |
| April 17, 2024 | -3.07M |
| April 16, 2024 | -3.078M |
| April 15, 2024 | -3.088M |
| April 12, 2024 | -2.943M |
| April 11, 2024 | -2.943M |
| April 10, 2024 | -3.037M |
| April 09, 2024 | -3.092M |
| April 08, 2024 | -3.096M |
| April 05, 2024 | -3.097M |
| April 04, 2024 | -3.034M |
| April 03, 2024 | -2.996M |
| April 02, 2024 | -2.806M |
| April 01, 2024 | -2.761M |
| March 28, 2024 | -2.897M |
| March 27, 2024 | -2.725M |
| Date | Value |
|---|---|
| March 26, 2024 | -2.856M |
| March 25, 2024 | -2.722M |
| March 22, 2024 | -2.842M |
| March 21, 2024 | -2.506M |
| March 20, 2024 | -2.280M |
| March 19, 2024 | -2.098M |
| March 18, 2024 | -2.007M |
| March 15, 2024 | -1.670M |
| March 14, 2024 | -1.735M |
| March 13, 2024 | -0.8253M |
| March 12, 2024 | -1.280M |
| March 11, 2024 | -1.280M |
| March 08, 2024 | -1.283M |
| March 07, 2024 | -1.053M |
| March 06, 2024 | -0.7376M |
| March 05, 2024 | -0.6049M |
| March 04, 2024 | -0.7548M |
| March 01, 2024 | -0.8363M |
| February 29, 2024 | -0.9181M |
| February 28, 2024 | -0.9544M |
| February 27, 2024 | -1.012M |
| February 26, 2024 | -0.8272M |
| February 23, 2024 | -0.7818M |
| February 22, 2024 | -1.091M |
| February 21, 2024 | -0.6546M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.853M
Minimum
Sep 21 2022
135.88M
Maximum
Nov 29 2021
10.67M
Average
0.326M
Median
Enterprise Value Benchmarks
| RadNet Inc | 4.389B |
| DermTech Inc | -34.40M |
| 23andMe Holding Co | -0.9597M |
| Sera Prognostics Inc | 289.45M |
| Progyny Inc | 2.744B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.073M |
| Revenue (Quarterly) | 2.575M |
| Total Expenses (Quarterly) | 5.446M |
| EPS Diluted (Quarterly) | -0.34 |
| Gross Profit Margin (Quarterly) | 44.58% |
| Profit Margin (Quarterly) | -119.3% |
| Earnings Yield | -464.2% |
| Normalized Earnings Yield | -464.15 |